Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity
Kichul Shin, Sung Soo Kim, Sang-Heon Lee, Seung-Jae Hong, Sung Jae Choi, Jung-Yoon Choe, Seung-Geun Lee, Hoon-Suk Cha, Eun Young Lee, Sung-Hwan Park, Jin-Wuk Hur, Sung Soo Na, Chang-Hee Suh, Min Wook So, Seung Won Choi, Dong-Hyuk Sheen, Won Park, Shin-Seok Lee, Wan Hee Ryu, Jin Seok Kim, Jung Soo Song, Hye Soon Lee, Seong Ho Kim, Dae-Hyun Yoo
Korean J Intern Med. 2020;35(1):231-239. Published online 2019 Jan 28 DOI: https://doi.org/10.3904/kjim.2018.137
Citations to this article as recorded by 
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study
Peter C Taylor, Georg Schett, Tom WJ Huizinga, Qingmin Wang, Fowzia Ibrahim, Bei Zhou, Sophia G Liva, Jafar Sadik B Shaik, Yuan Xiong, Jocelyn H Leu, Rohit A Panchakshari, Matthew J Loza, Keying Ma, Harman Dhatt, Ricardo Rojo Cella, Chetan S Karyekar, Car
RMD Open.2024; 10(2): e004278. CrossRef